You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II chronic lymphocytic leukemia

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma

Terminated
Has Results
  • Adult Grade III Lymphomatoid Granulomatosis
  • +116 more
  • brentuximab vedotin
  • +2 more
  • Chicago, Illinois
  • +2 more
Aug 30, 2021

Biomarker for Infection Risk in CLL and MM

Not yet recruiting
  • Multiple Myeloma
  • Chronic Lymphocytic Leukemia
  • Screening
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
May 3, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • High Dose Methylprednisolone (HDMP)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial run by the (Acalabrutinib (Arm A), Acalabrutinib (Arm B))

Active, not recruiting
Has Results
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Acalabrutinib (Arm A)
  • Acalabrutinib (Arm B)
  • Bethesda, Maryland
    Research Site
Jan 3, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

Recruiting
  • Relapsed or Refractory CD19+ B-cell Lymphoma
  • +2 more
  • TBI-2001
  • +2 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Jul 26, 2023

B-cell Chronic Lymphocytic Leukemia Trial in Peking (Alemtuzumab)

Suspended
  • B-cell Chronic Lymphocytic Leukemia
  • Alemtuzumab
  • Peking, Beijing, China
    Peking University Cancer Hospital
Jun 15, 2022

B-type Chronic Lymphocytic Leukemia Subgroups: Maturation Stage

Active, not recruiting
  • Chronic Lymphocytic Leukemia
    • Manhasset, New York
      Feinstein Institute for Medical research
    Jul 6, 2022

    Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Jul 19, 2023

    Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia Trial in

    Not yet recruiting
    • Recurrent Chronic Lymphocytic Leukemia
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 10, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Pirtobrutinib, Venetoclax)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 17, 2022

    B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

    Completed
    Has Results
    • B-cell Chronic Lymphocytic Leukemia
    • +4 more
    • alemtuzumab
    • +9 more
    • Rochester, Minnesota
      Mayo Clinic
    Jun 11, 2020

    Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • RP-3500 in combination with Olaparib
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Sep 23, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine Phosphate, Ibrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Chronic Lymphocytic Leukemia, Leukemia Trial in United States (Ibrutinib, Fludarabine, Cyclophosphamide)

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Leukemia
    • Coral Gables, Florida
    • +8 more
    Sep 28, 2022

    Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)

    Recruiting
    • Relapsed Chronic Lymphocytic Leukemia
    • Ann Arbor, Michigan
      University of Michigan Comprehensive Cancer Center
    May 11, 2022

    Orelabrutinib in the Treatment of CLL/SLL

    Not yet recruiting
    • CLL/SLL
      • (no location specified)
      Jul 26, 2023

      Leukemia, Lymphocytic, Chronic Trial in Germany (ibrutinib, obinutuzumab, venetoclax)

      Completed
      • Leukemia, Lymphocytic, Chronic
      • Dresden, Germany
      • +10 more
      Jan 13, 2023

      Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial in Scottsdale, Rochester (Biospecimen Collection, Cardiopulmonary

      Recruiting
      • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
      • Biospecimen Collection
      • +8 more
      • Scottsdale, Arizona
      • +1 more
      May 16, 2023

      Understanding Chronic Lymphocytic Leukemia

      Recruiting
      • Chronic Lymphocytic Leukemia
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Aug 1, 2022

        Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Questionnaires
        • Fit Bit
        • Houston, Texas
          M D Anderson Cancer Center
        May 18, 2023

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Columbus (Acalabrutinib, Obinutuzumab, Venetoclax)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 2, 2022

        Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma

        Completed
        Has Results
        • Adult Grade III Lymphomatoid Granulomatosis
        • +88 more
        • Detroit, Michigan
          Barbara Ann Karmanos Cancer Institute
        Apr 14, 2021

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Relapsed Chronic Lymphocytic Leukemia Trial in Boston (Acalabrutinib,

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • +3 more
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Dec 19, 2022

        Phase I: Relapsed or Refractory B-cell Malignancies, Phase II Cohort A: Relapsed or Refractory Mantle Cell Lymphoma, Phase II

        Active, not recruiting
        • Phase I: Relapsed or Refractory B-cell Malignancies
        • +2 more
        • Beijing, China
        • +22 more
        Dec 8, 2022